Press Release: Omeros : Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical Program
The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER)...
Read full article »
Omeros is a Wasington-based biopharmaceutical company that researches and develops small-molecule and protein therapeutics for the treatment of inflammation and CNS disorders.
Read more